Kun‐Yu Teng

1.2k citations
25 papers · 967 indexed · h-index 14
Topics
Immune Cell Function and Interaction (11 papers)CAR-T cell therapy research (6 papers)MicroRNA in disease regulation (5 papers)
Partner nations
United StatesChinaTaiwan

In The Last Decade

Kun‐Yu Teng

25 papers receiving 959 citations

Peers

Kun‐Yu Teng
Comparison fields: 5 of 76
  • Oncology 442
  • Molecular Biology 436
  • Immunology 329
  • Cancer Research 204
  • Genetics 106
Replace Masayuki Nagahashi with:
Masayuki Nagahashi Japan
Samuel Wormald Australia
Sailan Zou China
Akio Yamasaki Japan
Zhongguang Luo China
Guangyi Wang China
Pia Herrmann Germany
Haihua Qian China
Fang Xiong China
Kun‐Yu Teng relative to Masayuki Nagahashi Japan Masayuki Nagahashi's profile →
Citations per field
00.5×1.5×2.5×
Masayuki Nagahashi · 1×
Citations per year

Countries citing papers authored by Kun‐Yu Teng

Since Specialization
Citations

This map shows the geographic impact of Kun‐Yu Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun‐Yu Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun‐Yu Teng more than expected).

Fields of papers citing papers by Kun‐Yu Teng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun‐Yu Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun‐Yu Teng. The network helps show where Kun‐Yu Teng may publish in the future.

Co-authorship network of co-authors of Kun‐Yu Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Kun‐Yu Teng. A scholar is included among the top collaborators of Kun‐Yu Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun‐Yu Teng. Kun‐Yu Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 27
3 39
4 95
5 162
6 24
7 9
8 43
9 32
10 7
11
Molecular mechanisms underlying microRNA-122 mediated suppression of liver inflammation, fibrosis, and carcinogenesis
1
12 68
13 3
14 103
15 66
16 39
17 162
18 17
19 1
20 43

About Kun‐Yu Teng

Kun‐Yu Teng is a scholar working on Immunology, Oncology and Cancer Research, having authored 25 papers that have together received 967 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (11 papers), CAR-T cell therapy research (6 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Oncology (442 citations), Immunology (329 citations) and Cancer Research (204 citations). Kun‐Yu Teng has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Kalpana Ghoshal, Michael A. Caligiuri, Jianhua Yu, Anthony G. Mansour, Charles L. Shapiro, Jianying Zhang, Ting Lu, Bhuvaneswari Ramaswamy, Yuanzhi Lu and Sarmila Majumder. Their work appears in journals such as Nature Communications, Molecular Cell and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026